This Vanguard Built Market Rotation: Value Wins for 2026
As markets shift away from giant tech names, a Vanguard built market approach centers on value, dividends, and steady...
Market Rotation
This tag page curates four Market Rotation articles that explain how sector shifts and leadership changes can impact portfolios, helping you time moves and manage risk.
21 articles
VC Says ‘All Your Eggs in AI Basket’ Trade Cracking
A leading venture capitalist says the all-in AI trade is cracking as funding moves toward AI infrastructure and relat...
Planet Labs Sinks 10% as Space Stocks Rally Around SpaceX
Planet Labs sinks 10% in early trading as traders rotate capital toward SpaceX-linked opportunities, signaling a sect...
Bitcoin, Gold Post Worst YTD Slump Amid Market Rally
Bitcoin and gold are the lone red flags so far in 2026, underscoring a rare market rotation as equities rally and tra...
Value Stocks Win: This Flash Pan Is Not Over Yet Today
Value stocks are delivering sharp gains in 2026 as earnings growth broadens beyond technology. Investors warn this fl...
Stock Market Isn’t Crashing as Tech Stocks Pull Back
Tech stocks retreat sparked a broader market pause, but analysts insist the stock market isn’t crashing — it’s a rota...
Wall Street Strategist: SpaceX Spawns Major Market Repositioning
As SpaceX eyes a potential mega-IPO, a veteran market strategist says the issue could force a broad rotation, unlocki...
Investors Ditching Magnificent Group for the MANGOS Boom
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
Maxed TSMC, Samsung Hynix: EM Funds Hunt New Bets Today
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
Vanguard’s Value Soon Outperform as Migration Accelerates
As the Great Migration accelerates, Vanguard’s Value ETF is leading a rotation into cash-generative stocks, signaling...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Underdogs Driving S&P 500 Profit Growth at Five-Year High
The S&P 500 is posting its fastest earnings growth in nearly five years, led by under-the-radar firms across multiple...